SMTL ID : 7c2v.1

Crystal Structure of IRAK4 kinase in complex with the inhibitor CA-4948

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.44 Å

Oligo State

homo-tetramer

Ligands

4 x FJ0: 2-(2-methylpyridin-4-yl)-N-[2-morpholin-4-yl-5-[(3R)-3-oxidanylpyrrolidin-1-yl]-[1,3]oxazolo[4,5-b]pyridin-6-yl]-1,3-oxazole-4-carboxamide(Non-covalent)

FJ0.1: 15 residues within 4Å: Chain A: M.32, G.33, G.35, G.36, V.40, A.51, K.53, Y.102, V.103, Y.104, M.105, P.106, G.108, L.158, D.169 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.102, A:Y.104, A:L.158 Hydrogen bonds: A:K.53, A:M.105, A:D.169 Water bridges: A:E.34, A:S.109, A:R.113, A:R.113 FJ0.2: 17 residues within 4Å: Chain B: M.32, G.33, G.35, G.36, V.40, A.51, K.53, Y.102, V.103, Y.104, M.105, P.106, G.108, S.109, A.155, L.158, D.169 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:V.40, B:Y.102, B:Y.104, B:L.158 Hydrogen bonds: B:K.53, B:M.105, B:A.155, B:D.169 Water bridges: B:S.109, B:R.113 FJ0.3: 17 residues within 4Å: Chain C: M.32, G.33, G.35, G.36, V.40, A.51, K.53, E.73, Y.102, V.103, Y.104, M.105, P.106, G.108, A.155, L.158, D.169 8 PLIP interactions: 8 interactions with chain C Hydrophobic interactions: C:Y.102, C:Y.104 Hydrogen bonds: C:K.53, C:M.105, C:A.155, C:D.169 Water bridges: C:S.109, C:R.113 FJ0.4: 16 residues within 4Å: Chain D: M.32, G.35, V.40, A.51, K.53, E.73, Y.102, V.103, Y.104, M.105, P.106, G.108, S.109, R.113, L.158, D.169 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:Y.102, D:Y.104 Hydrogen bonds: D:K.53, D:M.105, D:D.169 Water bridges: D:D.112, D:D.112, D:R.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gummadi, V.R. et al., Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies. Acs Med.Chem.Lett. (2020)

Release Date

2020-11-25

Peptides

Interleukin-1 receptor-associated kinase 4: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Interleukin-1 receptor-associated kinase 4